Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
654 hedge funds and large institutions have $15.3B invested in Exact Sciences in 2023 Q2 according to their latest regulatory filings, with 127 funds opening new positions, 191 increasing their positions, 230 reducing their positions, and 52 closing their positions.
144% more first-time investments, than exits
New positions opened: 127 | Existing positions closed: 52
37% more capital invested
Capital invested by funds: $11.1B → $15.3B (+$4.12B)
12% more funds holding
Funds holding: 584 → 654 (+70)
9% more funds holding in top 10
Funds holding in top 10: 11 → 12 (+1)
3% more call options, than puts
Call options by funds: $208M | Put options by funds: $201M
1.3% less ownership
Funds ownership: 92.27% → 90.97% (-1.3%)
17% less repeat investments, than reductions
Existing positions increased: 191 | Existing positions reduced: 230
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PL
Parkwood LLC
Cleveland,
Ohio
|
+$101M |
| 2 |
JP Morgan Chase
New York
|
+$81.8M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$76.1M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$66.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$61.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$330M |
| 2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$88.4M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
-$86M |
| 4 |
AC
Armistice Capital
New York
|
-$69M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$47.8M |
EXAS Hedge Fund Activity: Q2 2023 in Review
654 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q2 2023, worth a combined $15.3B — up 37% from $11.1B a quarter earlier.
Buyers outnumbered sellers: 127 funds opened new EXAS positions and 52 closed out — a net gain of 75 holders — while 191 added to existing stakes and 230 trimmed.
The largest buyer was Parkwood LLC, opening a new position worth an estimated $101M. The largest seller was ARK Investment Management, cutting an estimated $330M.
- 654 institutional investors held Exact Sciences (EXAS) as of Q2 2023, up from 584 in Q1 2023.
- Funds reported $15.3B of Exact Sciences stock for Q2 2023, up 37% quarter-over-quarter.
- 127 funds opened new Exact Sciences positions in Q2 2023 and 52 closed out, a net change of +75 holders.
- The largest Exact Sciences buyer in Q2 2023 was Parkwood LLC, an estimated $101M added.
- The largest Exact Sciences seller in Q2 2023 was ARK Investment Management, an estimated $330M sold.
Based on aggregated 13F filings for Q2 2023.